0000899243-22-001749.txt : 20220112 0000899243-22-001749.hdr.sgml : 20220112 20220112160547 ACCESSION NUMBER: 0000899243-22-001749 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220101 FILED AS OF DATE: 20220112 DATE AS OF CHANGE: 20220112 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Smith W Bradford CENTRAL INDEX KEY: 0001317678 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38433 FILM NUMBER: 22526673 MAIL ADDRESS: STREET 1: C/O HOMOLOGY MEDICINES, INC. STREET 2: ONE PATRIOTS PARK CITY: BEDFORD STATE: MA ZIP: 01730 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Homology Medicines, Inc. CENTRAL INDEX KEY: 0001661998 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473468154 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE PATRIOTS PARK CITY: BEDFORD STATE: MA ZIP: 01730 BUSINESS PHONE: 781-301-7277 MAIL ADDRESS: STREET 1: ONE PATRIOTS PARK CITY: BEDFORD STATE: MA ZIP: 01730 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-01-01 0 0001661998 Homology Medicines, Inc. FIXX 0001317678 Smith W Bradford C/O HOMOLOGY MEDICINES INC., ONE PATRIOTS PARK BEDFORD MA 01730 0 1 0 0 CFO & Treasurer Common Stock 2022-01-01 4 M 0 6600 A 6600 D Common Stock 2022-01-05 4 S 0 2182 3.7802 D 4418 D Restricted Stock Units 2022-01-01 4 M 0 6600 0.00 D Common Stock 6600 13400 D Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of RSUs. The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $3.78 to $3.80. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 3. The RSUs have vested and settled or will vest and settle, as applicable, as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2021 so that such RSUs will become fully vested on January 1, 2024. The RSUs do not have an expiration date. /s/ W. Bradford Smith 2022-01-12